Epidermal growth factor receptor inhibitor-induced hypomagnesemia: a survey of practice patterns among Canadian gastrointestinal medical oncologists.

MLA

Thangarasa, T., et al. “Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesemia: A Survey of Practice Patterns among Canadian Gastrointestinal Medical Oncologists.” Current Oncology, vol. 26, no. 2, Apr. 2019, pp. e162–66. EBSCOhost, https://doi.org/10.3747/co.26.4591.

APA

Thangarasa, T., Gotfrit, J., Goodwin, R. A., Tang, P. A., Clemons, M., Imbulgoda, A., & Vickers, M. M. (2019). Epidermal growth factor receptor inhibitor-induced hypomagnesemia: a survey of practice patterns among Canadian gastrointestinal medical oncologists. Current Oncology, 26(2), e162–e166. https://doi.org/10.3747/co.26.4591

Chicago

Thangarasa, T., J. Gotfrit, R. A. Goodwin, P. A. Tang, M. Clemons, A. Imbulgoda, and M. M. Vickers. 2019. “Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesemia: A Survey of Practice Patterns among Canadian Gastrointestinal Medical Oncologists.” Current Oncology 26 (2): e162–66. doi:10.3747/co.26.4591.